Phenotyping of Chronic Pain in Diffused Systemic Scleroderma (PAIN SSc)
Scleroderma, Systemic, Scleroderma, Diffuse
About this trial
This is an interventional other trial for Scleroderma, Systemic focused on measuring scleroderma, phenotyping
Eligibility Criteria
Inclusion Criteria: Patients ≥ 18 years; Patients with diffused SSc according to ACR / EULAR Classification 2013 since at least 3 months; For group pain: pain intensity ≥4 of 11 points of scale (NRS); For group painless: pain intensity on the month before inclusion. Exclusion Criteria: Patients unable to understand french language; Patients no-affiliated to the french social security scheme; Patients under the french AME scheme; Patients under guardianship; Pregnant and breastfeeding patients; Patients with thermoalgesic neuropathy; Articular pain from degenerative diseases (known osteoarthritis); Patients under antidepressant; Temporary discontinuation of analgesics which are not well tolerated.
Sites / Locations
- Center of evaluation and treatment of pain - Cochin hospital - APHPRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
scleroderma with pain
scleroderma without pain
systemic sclerosis (SSc) with chronic pain
systemic sclerosis patients without chronic pain